Anavex Life Sciences (AVXL) had the highest return in 2015 by a small-cap US stock, returning 632.9%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Anavex Life Sciences (AVXL) | 2015 | 632.89% |
Prothena (PRTA) | 2015 | 224.33% |
LightPath Technologies (LPTH) | 2015 | 211.23% |
eXp World (EXPI) | 2015 | 184.69% |
LeMaitre Vascular (LMAT) | 2015 | 137.18% |
Smith & Wesson Brands (SWBI) | 2015 | 130.16% |
Collegium Pharmaceutical (COLL) | 2015 | 129.17% |
Airnet Technology (ANTE) | 2015 | 119.22% |
Iradimed (IRMD) | 2015 | 118.99% |
Frp Holdings Ord (FRPH) | 2015 | 106.46% |
Lexicon Pharmaceuticals (LXRX) | 2015 | 104.45% |
MaxLinear (MXL) | 2015 | 97.19% |
American Woodmark (AMWD) | 2015 | 96.66% |
Amark Preci (AMRK) | 2015 | 95.49% |
DiaMedica Therapeutics (DMAC) | 2015 | 93.88% |
Five9 (FIVN) | 2015 | 93.76% |
Amarin (AMRN) | 2015 | 92.86% |
NeoGenomics (NEO) | 2015 | 91.96% |
Cantaloupe (CTLP) | 2015 | 90.12% |
Volaris (VLRS) | 2015 | 89.2% |
Rocket Pharmaceuticals (RCKT) | 2015 | 85.74% |
Hackett (HCKT) | 2015 | 85.2% |
Empresa Distribuidora y Comercializadora Norte SA ADR (EDN) | 2015 | 85.11% |
Lendingtree (TREE) | 2015 | 84.08% |
Genie Energy (GNE) | 2015 | 83.63% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
